Nanotechnology firm Liquidia partners with PATH on new pneumonia vaccine
North Carolina nanotechnology company Liquidia Technologies is partnering with nonprofit organization PATH to develop a new pneumonia vaccine that could be deployed globally. Research Triangle Park-based Liquidia is working with PATH to conduct preclinical studies on a “next-generation” pneumococcal vaccine that could be more effective than existing vaccines and more efficient to produce. Financial terms […]